Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma
- PMID: 18528306
- DOI: 10.1097/MLG.0b013e3181781791
Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma
Abstract
Objective/hypothesis: The purpose of this study is to determine the prognostic factors for local control and significance of total radiation dose in T1 glottic cancer.
Study design: Retrospective study.
Methods: Data from 163 patients with T1 N0 M0 Stage I glottic squamous cell carcinoma (T1a: 115, T1b: 48) who were treated with radiotherapy alone during 1976 to 2002 were analyzed retrospectively. Age, source, total dose, field size, overall treatment time, and average fraction size were set as variables in multivariate analysis.
Results: The 5-year local control rates (LCR) were 92.3% and 85.0% for patients with T1a and T1b glottic carcinoma, respectively. Only total radiation dose (P = .048) was a significant prognostic factor for local control in multivariate analysis of T1b glottic carcinoma. Local control in the higher total dose group was better than that in the lower total dose group (5 year LCRs were 100% and 76% for the group of > 66 Gy and the group of < or = 66 Gy, respectively. P = .024, logrank test). None of the treatment parameters were shown to be significant prognostic factors in multivariate analysis of T1a glottic carcinoma.
Conclusions: Radiotherapy with a total dose of 67 to 70 Gy seemed to be required for local control in T1b glottic carcinoma. No significant benefit of total radiation dose > 64 Gy was shown in the analysis of T1a glottic carcinoma.
Similar articles
-
Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.Strahlenther Onkol. 2004 Feb;180(2):84-90. doi: 10.1007/s00066-004-1164-y. Strahlenther Onkol. 2004. PMID: 14762660
-
Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.Cancer. 2003 Aug 15;98(4):765-72. doi: 10.1002/cncr.11575. Cancer. 2003. PMID: 12910521
-
Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.Radiat Oncol Investig. 1999;7(1):42-8. doi: 10.1002/(SICI)1520-6823(1999)7:1<42::AID-ROI6>3.0.CO;2-W. Radiat Oncol Investig. 1999. PMID: 10030623
-
Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.Am J Otolaryngol. 2001 Jan-Feb;22(1):43-54. doi: 10.1053/ajot.2001.20679. Am J Otolaryngol. 2001. PMID: 11172214 Review.
-
[Radiotherapy of cancer limited to the vocal cords].Ann Otolaryngol Chir Cervicofac. 1989;106(8):577-82. Ann Otolaryngol Chir Cervicofac. 1989. PMID: 2694896 Review. French.
Cited by
-
Nomogram for predicting survival in T1-T2 stage patients with supraglottic squamous cell carcinoma.Discov Oncol. 2024 May 8;15(1):147. doi: 10.1007/s12672-024-01015-y. Discov Oncol. 2024. PMID: 38717631 Free PMC article.
-
Assessment of disease-free survival in patients with laryngeal squamous cell carcinoma treated with radiotherapy associated or not with chemotherapy.Braz J Otorhinolaryngol. 2010 Mar-Apr;76(2):225-30. doi: 10.1590/S1808-86942010000200013. Braz J Otorhinolaryngol. 2010. PMID: 20549084 Free PMC article.
-
Transoral laser microsurgery for T1b glottic cancer: review of 51 cases.Eur Arch Otorhinolaryngol. 2017 Apr;274(4):1997-2004. doi: 10.1007/s00405-016-4432-4. Epub 2016 Dec 27. Eur Arch Otorhinolaryngol. 2017. PMID: 28028607
-
Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.Radiat Oncol. 2012 Nov 19;7:193. doi: 10.1186/1748-717X-7-193. Radiat Oncol. 2012. PMID: 23164282 Free PMC article.
-
Multi-institutional analysis of early glottic cancer from 2000 to 2005.Radiat Oncol. 2012 Aug 1;7:122. doi: 10.1186/1748-717X-7-122. Radiat Oncol. 2012. PMID: 22853797 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources